These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32060890)

  • 1. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    Takenaga K; Akimoto M; Koshikawa N; Nagase H
    PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the IL-33/ST2L axis in colorectal cancer progression.
    Akimoto M; Takenaga K
    Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
    Hong J; Kim S; Lin PC
    J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-33/ST2 axis: Role in health and disease.
    De la Fuente M; MacDonald TT; Hermoso MA
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
    Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
    J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble ST2: A complex and diverse role in several diseases.
    Homsak E; Gruson D
    Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment.
    Akimoto M; Maruyama R; Takamaru H; Ochiya T; Takenaga K
    Nat Commun; 2016 Nov; 7():13589. PubMed ID: 27882929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 Controls IL-33 Activity through Modulation of ST2.
    Zhang M; Duffen JL; Nocka KH; Kasaian MT
    J Immunol; 2021 Dec; 207(12):3070-3080. PubMed ID: 34789557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble ST2 suppresses IL-5 production by human basophilic KU812 cells, induced by epithelial cell-derived IL-33.
    Matsumoto K; Kouzaki H; Kikuoka H; Kato T; Tojima I; Shimizu S; Shimizu T
    Allergol Int; 2018 Sep; 67S():S32-S37. PubMed ID: 29941231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2--analytical considerations.
    Mueller T; Jaffe AS
    Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of ST2: the International ST2 Consensus Panel.
    Pascual-Figal DA; Januzzi JL
    Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33/ST2 as a potential target for tumor immunotherapy.
    Jiang W; Lian J; Yue Y; Zhang Y
    Eur J Immunol; 2021 Aug; 51(8):1943-1955. PubMed ID: 34131922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of IL-33/ST2 Pathway in Tumorigenesis.
    Larsen KM; Minaya MK; Vaish V; Peña MMO
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
    Hayakawa H; Hayakawa M; Kume A; Tominaga S
    J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33 in Malignancies: Friends or Foes?
    Shen JX; Liu J; Zhang GJ
    Front Immunol; 2018; 9():3051. PubMed ID: 30619376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST2/IL-33 signaling in cardiac fibrosis.
    Vianello E; Dozio E; Tacchini L; Frati L; Corsi Romanelli MM
    Int J Biochem Cell Biol; 2019 Nov; 116():105619. PubMed ID: 31561019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF-nuclear IL-33-GATA3 pathway.
    Akimoto M; Susa T; Okudaira N; Koshikawa N; Hisaki H; Iizuka M; Okinaga H; Takenaga K; Okazaki T; Tamamori-Adachi M
    Proc Natl Acad Sci U S A; 2023 May; 120(18):e2218033120. PubMed ID: 37094129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Production of Soluble ST2 in Heart Failure.
    Pascual-Figal DA; Pérez-Martínez MT; Asensio-Lopez MC; Sanchez-Más J; García-García ME; Martinez CM; Lencina M; Jara R; Januzzi JL; Lax A
    Circ Heart Fail; 2018 Dec; 11(12):e005488. PubMed ID: 30562096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.